pazopanib_NCRCC,Ph2 STUDY

NCT01538238 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Locally Advanced or Metastatic Non-clear Cell Type Renal Cell Carcinoma

Interventions

DRUG: pazopanib

Sponsor

Samsung Medical Center